Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
Background. The decline of Helicobacter pylori (H. pylori) eradication rates with standard triple therapy resulted in a search for novel therapies for first-line therapy of H. pylori infection. Aim. The aim of the study is to compare the efficacy of concomitant therapy with sequential therapy as the...
Saved in:
Main Authors: | Sung Min Jung, Dae Young Cheung, Jin Il Kim, Il Kim, Hyeonjin Seong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/1293649 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
by: Meng-Chieh Wu, et al.
Published: (2017-01-01) -
7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan
by: Sung-Shuo Kao, et al.
Published: (2012-01-01) -
Utility of Serology in Determining Helicobacter pylori Eradication after Therapy
by: Carlo A Fallone, et al.
Published: (1998-01-01) -
The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
by: Chao-Hung Kuo, et al.
Published: (2012-01-01) -
Rational choice of eradication therapy of <i>Helicobacter pylori</i> infection
by: T. L. Lapina, et al.
Published: (2013-10-01)